Patents/Inventors

Rajkumar Ganesan

Blue Bell, PAUS24 patents

25 Patents

US125288792026
Multi-specific Binding Proteins for Cancer Treatment
Boehringer Ingelheim International GmbH
0 cites
US124922262025
Materials and Methods for Producing Bioengineered Virus Specific Lymphocytes
JANSSEN BIOTECH, Inc.
0 cites
US124922562025
Methods and Compositions for Modulating Beta Chain Mediated Immunity
JANSSEN BIOTECH, Inc.
0 cites
US124600012025
Proteins Comprising CD3 Antigen Binding Domains and Uses Thereof
Janssen Biotech, Inc.
0 cites
US124484492025
Immune Targeting Molecules and Uses Thereof
Janssen Biotech, Inc.
0 cites
US122641972025
Anti-vβ17/anti-cd123 Bispecific Antibodies
JANSSEN BIOTECH, Inc.
0 cites
US121802782024
Antibody Targeting CD22 and CD79B
Janssen Biotech, Inc.
0 cites
US121730832024
Multi-specific Binding Proteins for Cancer Treatment
Boehringer Ingelheim International GmbH
0 cites
US121346582024
Materials and Methods for Multidirectional Biotransportation in Virotherapeutics
JANSSEN BIOTECH, Inc.
0 cites
US121293102024
Materials and Methods for Enhanced Linker Targeting
JANSSEN BIOTECH, Inc.
0 cites
US121039772024
Trispecific Antibody Targeting Cd79b, CD20, and CD3
Janssen Biotech, Inc.
0 cites
US120845012024
Proteins Comprising CD3 Antigen Binding Domains and Uses Thereof
Janssen Biotech, Inc.
0 cites
US120764132024
Compositions and Methods for Modulating Delta Gamma Chain Mediated Immunity
JANSSEN BIOTECH, Inc.
0 cites
US120775852024
Proteins Comprising Kallikrein Related Peptidase 2 Antigen Binding Domains and Their Uses
Janssen Biotech, Inc.
0 cites
US120775922024
GPRC5D Chimeric Antigen Receptors and Cells Expressing the Same
Janssen Biotech, Inc.
0 cites
US120714662024
Anti-human Kallikrein-2 (hk2) Chimeric Antigen Receptor (CAR) and Methods of Use Thereof
Janssen Biotech, Inc.
0 cites
US119819322024
Materials and Methods for the Manufacture of Pluripotent Stem Cells
JANSSEN BIOTECH, Inc.
0 cites
US119650242024
Methods and Compositions for Modulating Beta Chain Mediated Immunity
Janssen Biotech, Inc.
0 cites
US119524112024
Materials and Methods of Using Engineered Ligands
Janssen Biotech, Inc.
0 cites
US119266672024
Bioengineered T Cell Mediated Immunity, Materials and Other Methods for Modulating Cluster of Differentiation IV And/or VIII
Janssen Biotech, Inc.
0 cites
US118664992024
Monospecific and Multispecific Anti-tmeff2 Antibodies and Their Uses
Janssen Biotech, Inc.
0 cites
US118277082023
Proteins Comprising HLA-G Antigen Binding Domains and Their Uses
Janssen Biotech, Inc.
0 cites
US117320452023
Multi-specific Binding Proteins for Cancer Treatment
Boehringer Ingelheim International GmbH
0 cites
US116677122023
Materials and Methods for Modulating T Cell Mediated Immunity
JANSSEN BIOTECH, Inc.
0 cites
US116393962023
Antibody Binding to a Linker Peptide
Janssen Biotech, Inc.
0 cites